Porcilis PCV ID
Active substance
ATC code
Species
Pigs.
Indications
For the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by PCV2 infection. To reduce loss of daily weight gain and mortality associated with PCV2 infection.
Onset of immunity: 2 weeks after vaccination.
Duration of immunity: 23 weeks after vaccination.
Dose to be administered and administration route
For intradermal use.
Before using the vaccine allow it to reach room temperature (15 °C-25 °C) and shake well before use. Avoid multiple broaching.
Intradermal administration of 0.2 ml per animal, preferably at the sides of the neck, along the muscles of the back or in the hind leg (all pigs) or perianal area (in pigs for reproduction) using a multi-dose needle-free injection device for intradermal application of liquids suitable to deliver a “jet-stream” volume of vaccine (0.2 ml ± 10 %) through the epidermal layers of the skin.
Safety and efficacy of Porcilis PCV ID have been demonstrated using the device IDAL.
Vaccination scheme:
Vaccinate once from an age of 3 weeks onwards and re-vaccination at 23 weeks interval is recommended.
Mixed use with Porcilis Lawsonia ID
Porcilis PCV ID may be used to reconstitute Porcilis Lawsonia lyophilisate shortly before vaccination in pigs from 3 weeks of age onwards as follows:
Porcilis Lawsonia ID lyophilisate | Porcilis PCV ID |
50 doses | 10 ml |
100 doses | 20 ml |
For proper reconstitution and correct administration, use the following procedure:
1. Allow Porcilis PCV ID to reach room temperature and shake well before use.
2. Add approximately 5-10 ml of Porcilis PCV ID to the Porcilis Lawsonia ID lyophilisate and mix briefly.
3. Withdraw the reconstituted concentrate from the vial and transfer it back into the vial with the Porcilis PCV ID. Shake briefly to mix.
4. Use the vaccine suspension within 6 hours of reconstitution. Any vaccine remaining at the end of this time should be discarded.
Dosage:
A single dose (0.2 ml) of Porcilis Lawsonia ID mixed with Porcilis PCV ID is given intradermally in the neck.
Visual appearance after reconstitution: homogenous white to nearly white emulsion after shaking.
Avoid introduction of a contamination by multiple broaching.
Adverse reactions
Pigs:
Very common (>1 animal / 10 animals treated): | Injection site swelling* |
* mostly consisting of hard non-painful swellings of up to 2 cm diameter. A biphasic pattern of the injection site swelling, consisting of an increase and decrease followed by another increase and decrease of the size, is commonly observed. In individual pigs the size may increase to 6.5 cm and redness and/or scabs may be observed. The injection site swellings disappear completely within approximately 7 weeks after vaccination
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the last section of the package leaflet for respective contact details.
